STAT reporter Eric Boodman writes that MIT researchers have engineered living materials that glow when they detect certain chemicals. Boodman notes that the researchers hope the living sensors “could at some point be used to pick up dangerous toxins or the chemical signs of disease.”
New Scientist reporter Sam Wong writes that MIT researchers used high-speed cameras to examine how raindrops can spread soil bacteria. “The researchers estimate that a single raindrop can transfer 0.01 per cent of bacteria on the soil surface into the air, and up to a quarter of bacteria emitted from the land might become airborne in this way.”
Using high-speed cameras and fluorescent dye, MIT researchers have uncovered how rain drops can spread soil bacteria, reports Rae Ellen Bichell for NPR. The researchers found that in a few microseconds “a single raindrop can create hundreds of tiny airborne droplets, each one carrying as many as several thousand live bacteria.”
Popular Science reporter Kendra Pierre-Louis writes about a new study by MIT researchers that examines how rain drops help spread soil bacteria. The researchers found that “a single rain drop can transfer 0.01 percent of bacteria on the soil surface to the atmosphere.”
Researchers at MIT have designed a new living material infused with cells that could one day be used as a wearable sensor, writes Brooks Hays for UPI. The researchers used the new material to “design gloves and bandages that light up when they come in contact with target chemicals.”
In an article for Popular Science, Kate Baggaley speaks with Prof. Timothy Lu and postdoc César de la Fuente about strategies they are developing to tackle antibiotic resistance. Lu explains that researchers are attempting to develop an arsenal of treatments to “be able to come at the problem from a variety of different ways.”
Popular Science reporter Sarah Chodosh writes that MIT researchers have developed a strategy to deliver beneficial bacteria to the GI tract. The researchers used layers of different sugars "to coat individual cells of Bacillus coagulans, which is used to treat irritable bowel syndrome."
Angus Chen reports for NPR that MIT and Harvard researchers have captured footage showing bacteria invading antibiotics and transforming into superbugs. Postdoc Tami Lieberman explains that she hopes the visualization will help illustrate that “drug resistance is not some abstract threat. It's real."
MIT spinoff Sample6 has raised $12.7 million to create a better system for detecting bacteria in food, writes Luke Timmerman for Forbes. “The company has developed a technology that can target specific bioparticles, light them up and do it without enriching the sample,” explains Timmerman.
Boston Magazine reporter Dana Guth writes that MIT researchers are programming harmless strains of E. coli bacteria to destroy tumor cells. Guth explains that the programmed bacteria could be ingested or injected and “could offer a new way to stave off liver cancer.”
MIT researchers have developed a portable system that could produce biotech drugs on demand, reports Lisa Rapaport for Reuters. “The table-top machine has the potential to one day produce proteins to treat any number of a wide range of conditions like cancer, diabetes, heart attacks, and hemophilia,” writes Rapaport.
A portable device developed by MIT researchers uses programmable yeast to create drugs on demand, reports Jamie Ducharme for Boston Magazine. The device “could be a lifesaver for doctors working in vulnerable conditions, such as the battlefield, a remote village, or even an ambulance,” writes Ducharme.
Popular Science reporter Samantha Cole writes that MIT researchers have developed a laptop-sized, portable device that can produce biopharmaceuticals for doctors in remote locations. Cole explains that the device can “produce a single dose of treatment with a series of steps, using genetically engineered yeast cells as a mini 'factory' for a variety of customizable drugs.”
Boston Herald reporter Lindsay Kalter writes that MIT researchers have developed a portable pharmacy that can manufacture biopharmaceuticals and modify treatments. “Instead of relying on a cocktail that already exists, you can reprogram the reactor on demand to customize the treatment,” says Prof. Timothy Lu.
A new study co-authored by researchers at the Broad Institute examines how exposure to microbes during childhood can impact the development of immune systems, reports Elissa Strauss for Slate. The researchers found that “while our individual habits are a factor in autoimmune disorders, they’re hardly the only cause.”